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Abstract
Background: Rapid-onset dystonia-parkinsonism (RDP) is a rare autosomal dominant disorder that is caused by
mutations in the ATP1A3 gene and is characterized by an acute onset of asymmetric dystonia and parkinsonism. To
date, fewer than 75 RDP cases have been reported worldwide. Clinical signs of pyramidal tract involvement have
been reported in several RDP cases, and none of them included the Babinski sign.
Case presentation: We report a 24-year-old Chinese female with RDP who exhibited a strikingly asymmetric,
predominantly dystonic movement disorder with a rostrocaudal gradient of involvement and parkinsonism. Physical
examiniations revealed hyperactive reflexes, bilateral ankle clonus and positive Babinski sign in the right. DTI
showed reduced white matter integrity of the corticospinal tract in the frontal lobe and subpontine plane. Genetic
testing revealed a missense mutation of the ATP1A3-gene (E277K) in the patient.
Conclusion: We suggest that pyramidal tract impairment could be involved in rapid-onset dystonia-parkinsonism
and the pyramidal tract impairment in RDP needs to be differentiated from HSP.
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Background
Rapid-onset dystonia-parkinsonism (RDP, DYT12) is a
rare autosomal dominant movement disorder with vari-
able expressivity and reduced penetrance that is caused
by a mutation of ATP1A3 (Na+/K+ −ATPase α3 subunit
gene) located on chromosome 19 [1]. To date, epidemio-
logical data related to RDP is limited and fewer than 75
RDP cases have been reported worldwide [2].
RDP is characterized by the sudden onset of asymmet-
ric dystonia and parkinsonism and presents a clear
rostrocaudal gradient of symptoms (face > arms > legs)
and prominent bulbar involvement [3, 4]. To our know-
ledge, clinical signs of pyramidal tract involvement have
been reported in several RDP cases, but none of them
included the Babinski sign. Although both the brisks
reflexes and the ankle clonus exhibited in several RDP
cases, scarce articles have discussed the pyramidal tract
dysfunction in RDP. Here, we describe a Chinese RDP
case with the Babinski sign, which indicates significant
pyramidal tract impairment.
Case presentation
A 24-year-old Chinese female with severe speech and
swallowing difficulties, prominent lower lip concavity,
and walking difficulties was admitted to our institution
in July 2015. In 2006, she displayed abnormal right leg
posture while running. She was unaware of the abnor-
mality until her father told her. In 2012, she suffered
from right leg spasms while sleeping as well as notable
gait disturbance. In April 2015, she displayed dragging
of the right leg with involuntary inversion of the right
ankle and slowness of movement. In May 2015, she ex-
perienced an acute onset of severe speech and swallow-
ing difficulties, and these symptoms were followed by
drooling, prominent lower lip concavity and dystonic
right hand postures several days later. The symptoms
slightly progressed over 1 week and then stabilized.
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Subsequently, her symptoms fluctuated frequently over a
1 week period. Depression and anxiety could worsen her
symptoms. The patient presented with global develop-
mental delay since early childhood and exhibited no pre-
ceding illness or drug use. There was no family history
of dystonia or Parkinson’s disease (Fig. 1). The patient’s
mother died of cerebrovascular disease at 30 years old.
The patient displayed prominent lower lip inversion
(Fig. 2). Due to severe hypokinesia of the tongue she was
anarthric. The muscle strength was normal. She pre-
sented cogwheel rigidity of her right arm and both legs,
particularly the right leg. She also showed markedly slow
movements, including finger and feet tapping. Deep ten-
don reflexes of the legs were hyperactive. Ankle clonus
was present bilaterally with more than 3 cloni. The right
foot displayed a positive Babinski sign, whereas the left
displayed a suspicious positive.
Both laboratory tests and routine cerebrospinal fluid
(CSF) studies were normal. Diffusion tensor imaging
(DTI; Fig. 3) showed reduced white matter integrity of
the corticospinal tract in the frontal lobe and subpontine
plane. Genetic tests for spinocerebellar ataxia (SCA) and
hereditary spastic paraplegia (HSP) yielded negative
results (HSP-associated and SCA associated genes in-
cluded in the gene sequencing of the patient were shown
in Additional file 1.). Next-generation sequencing of the
patient revealed a heterozygous nucleotide substitution
(c.829G > A) in ATP1A3 gene in exon 8 of chromosome
19, resulting in an amino acid substitution of glutamic
acid (E) to lysine (K) at codon position 277 (p.E277K),
which her father did not carry (Fig. 4) (Dystonia-associ-
ated genes included in the gene sequencing of the pa-
tient were shown in Additional file 2).
The symptoms appeared to be slightly improved by
the administration of trihexyphenidyl and baclofen.
When she was admitted at our institution again 4
months later, ankle clonus and a positive Babinski sign
were not observed, but deep tendon reflexes of the legs
remained brisk.
Conclusion
RDP (OMIM #128235), which was first reported by Dobyns
in 1993 [5], has been linked to various mutations in the
ATP1A3 [1, 3], which encodes the α3 subunit of the Na+/K
+ −ATPase. The Na+/K+ −ATPase (sodium pump), which
pumps three molecules of Na + out of and two molecules
of K+ into cells, is highly expressed in the basal ganglia,
cerebellum, thalamic nuclei, hippocampus and several areas
of the pons [6] and plays an important role in maintaining
the electrochemical gradient at the plasma membrane prior
to depolarization [7]. ATP1A3 gene has been involved in
five clinical neurological entities [8]: (1) RDP; (2) alternating
hemiplegia of childhood (AHC); (3) CAPOS (cerebellar
ataxia, areflexia, pes cavus, optic atrophy, sensorineural
hearing loss) syndrome; (4) early infantile epileptic enceph-
alopathy; and (5) Relapsing encephalopathy with cerebellar
ataxia (RECA).
Fig. 1 The pedgree for this patient. Squares indicate males; circles, females; arrow, proband; filled circle, affected female; circle with oblique line,
died female
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Fig. 2 Prominent lower lip concavity in our patient. Our patient presented prominent lower lip concavity, as shown in the picture
Fig. 3 Diffusion tensor imaging (DTI) of the patient. Diffusion tensor imaging (DTI) showed reduced white matter integrity of the corticospinal tract in
the frontal lobe and subpontine plane. The left side of corticospinal tract showed more sparse in the frontal lobe and subpontine plane than the other
side (filled triangles in white shown in picture d, e, f). Also, we could find some interruption in left side of corticospinal tract (arrows in yellow in picture
a, b, c, e, f). In addition, we could still see some interruption in the right side of corticospinal tract (arrows in yellow in picture c)
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To date, 12 missense mutations, two 3-bp deletions
and one 3-bp insertion in the ATP1A3 gene have been
reported to be associated with RDP [4, 9]. The patient
we presented had the E277K mutation, which has been
previously reported in three individuals with adult-onset
RDP [1, 3, 10]. RDP-associated ATP1A3 mutations are
inherited in an autosomal dominant fashion but also
frequently occur de novo [3, 4, 11]. We could not deter-
mine whether the patient’s mutation appeared de novo
because the patient’s mother was deceased. However,
there was no family history of dystonia or Parkinson dis-
ease, suggesting that our patient is likely a sporadic case.
Our patient displayed prominent lower lip inversion, a
symptom that has not been described in previously re-
ported RDP cases and was probably caused by the orofa-
cial dystonia [3, 4, 10]. The patient had severe bulbar
symptoms (dysarthria and dysphagia) and mild dystonia
in her right arm and leg, consistent with the rostrocau-
dal gradient and asymmetric involvement of symptoms
(face > arm > leg) in RDP [1, 3, 4].
About 13 reported RDP cases showed brisk reflexes on
physical exammination, with only 2 cases performed
ankle clonus simultaneously, but none of them exhibited
the Babinski sign [5, 10, 12–16]. Although both the
brisks reflexes and the ankle clonus exhibited in several
RDP cases, scarce articles have discussed the pyramidal
tract dysfunction in RDP [2]. However, Oblak et al. [2]
reported neuropathological investigations in 4 siblings
with RDP and described the involvement of corticospinal
tract in RDP. Also, recent DTI studies have suggested
that altered microstructural integrity of brainstem path-
ways and adverse interactions between the cerebellum
and basal ganglia may contribute to the development of
idiopathic early-onset dystonia [17, 18]. Our patient ex-
hibited both ankle clonus and a positive Babinski sign,
which were caused by impairment of the pyramidal tract.
DTI in our patient revealed decreased white matter in-
tegrity of the corticospinal tract in the frontal lobe and
subpontine plane, providing evidence of pyramidal tract
impairment.
The pyramidal tract impairment in the patient needs to
be differentiated from hereditary spastic paraplegia (HSP).
In the diagnosis of our patient, we realized the pyramidal
tract impairment and the dystonia in our patient at first,
which indicates the probable diagnosis of HSP. As compli-
cated HSP could encompass the parapyramidal signs (in-
cluding dystonia), for example in SPG21,SPG35,SPG56
[19, 20], so we take the next-gene sequencing on HSP.
And the gene test of HSP was negative, which excluded
SPG1-39,SPG41-56,SPG61-74,SCA5,SCA7-16,SCA19,SCA
22-23, SCA26-28, SCA34-36 and so on (see in Additional
file 1).
However, approximately 4 months after the diagnosis
was made and a treatment with baclofen and trihexyphe-
nidyl was started, and when our patient was re-admitted
to our clinic, she not only got better in drooling and walk-
ing, but also could speak single syllable. But the psychiary
symptoms, such as anxiety, depression, were much worse.
Fig. 4 Next-generation sequencing of the patient and her father. Next-generation sequencing of the patient revealed a heterozygous nucleotide
substitution (c.829G > A) in ATP1A3 gene in exon 8 of chromosome 19 (chr19:42489234) (a). Next-generation sequencing of the patient’s father
revealed no nucleotide substitution in ATP1A3 gene (b)
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She even had violent behaviours sometimes. On neuro-
logical examination, the ankle clonus and Babinski sign
were no longer present, but the deep tendon reflexes of
the legs were hyperactive. Baclofen is a GABA-B autore-
ceptor agonist that has been used to treat spasticity [21]
and dystonia [22], and trihexyphenidyl is an anticholiner-
gic agent that has proven effective for the symptomatic
treatment of dystonia in young patients [23]. Furthermore,
Almeida GL et al. reported an 11-year-old boy with spastic
diplegia cerebral palsy and found that ankle clonus and
Babinski reflexes could be decreased during balofen ad-
ministration [24]. The treatment with baclofen and trihex-
yphenidyl could have contributed to the resolution of the
ankle clonus and Babinski sign; however, the real reason is
unknown.
No curative treatment for RDP is currently available [1,
3]. The trihexyphenidyl and baclofen treatment provided
limited benefits to the patient. In the future, therapies
aimed at the Na+/K+-ATPase pump may be effective treat-
ments for RDP.
Additional files
Additional file 1: HSP-associated and SCA-associated genes included in
the gene sequencing of the patient. (DOC 98 kb)
Additional file 2: Dystonia-associated genes included in the gene
sequencing of the patient. (DOC 40 kb)
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